The radiocompound, namely 89Zr-DFO-J591, was tested first in vitro and then in 2 groups of nude mice bearing sub-cutaneous LNCaP (PSMA positive) or PC-3 (PSMA negative) tumor xenografts. This evidence concerns the gene FOLH1 and neoplasm.